Erythropoietin for anaemia in cancer patients

Eur J Cancer. 1993;29A Suppl 2:S2-8. doi: 10.1016/s0959-8049(05)80281-3.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Anemia / etiology
  • Anemia / therapy*
  • Antineoplastic Agents / adverse effects
  • Blood Transfusion
  • Bone Marrow / pathology
  • Cisplatin / adverse effects
  • Double-Blind Method
  • Erythropoietin / adverse effects
  • Erythropoietin / therapeutic use*
  • Female
  • Hematocrit
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasms / complications*
  • Quality of Life
  • Recombinant Proteins / therapeutic use

Substances

  • Antineoplastic Agents
  • Recombinant Proteins
  • Erythropoietin
  • Cisplatin